STAT
STAT+: In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugs
28, 2026 Europe Correspondent Andrew Joseph[email protected]Andrew covers the biopharma industry, scientific research,…
health · source
STAT News on WeSearch
Recent health headlines from STAT News.
Lead story
STAT
Why are drug overdose deaths declining?
Naloxone and harm reduction measures may be helping to curb drug overdose deaths, a new report says.
The latest
STAT
Opinion: Medical aid in dying and the burden of choosing to live
“Once medical aid in dying becomes available, the status quo changes,” writes Monika Piotrowska.
STAT
Opinion: Many post-Dobbs abortion fears have not come to pass. What does that mean for advocates?
OpinionFirst Opinion Many post-Dobbs abortion fears have not come to pass. Arguments about abortion rights should be…
STAT
STAT+: When it comes to women’s health, money talks
Women's health experts suggest a 'reverse pitch' approach to endometriosis, osteoporosis, and autoimmune treatments,…
STAT
STAT+: New treatments for common cardiovascular risk factor near the market, with billions at stake
STAT PlusPharma New treatments for common cardiovascular risk factor near the market, with billions at stake Unlike…
STAT
STAT+: Lady Gaga and her fiancé launch a biotech startup
FTC challenges Amgen's Enbrel patent strategy, the long, winding path for the Moderna-Merck cancer vaccine, and more…
STAT
STAT+: Public-sector purgatory, and a union-hospital fight
24, 2026 Business of Health Care Reporter Bob Herman[email protected]Bob covers the money in health care, focusing on…
STAT
Americans bought 12% less soda under new SNAP restrictions, study says
24, 2026 Reporter, Commercial Determinants of Health Sarah Todd[email protected]Sarah covers how industries like food…
STAT
STAT+: Experts scrutinize Huidagene’s disclosures after patient death
Merck and Moderna's mRNA cancer vaccine, an expected nominee to lead the FDA, and more biotech news from The Readout
STAT
Trust in science: A new STAT initiative
Dear Readers, When we launched STAT more than a decade ago, our mission statement promised that we would deliver…
STAT
Physician group sues Trump administration over dietary guidelines process
The suit, brought by a nonprofit that advocates for plant-based diets, claims HHS and the USDA used a “secret panel”…
STAT
STAT+: Government workers feel the squeeze on health care
Municipalities are struggling with the cost of health insurance for their workers, and states are facing a major…
STAT
STAT+: Pharmalittle: We’re reading about a setback for Eyepoint, a win for Amylyx, and more
Eyepoint disclosed that a Phase 3 trial of its experimental treatment for a common cause of age-related blindness fell…
STAT
STAT+: Prominent AI startup rolls out virtual cell model in race to speed up science
Zoom in closely enough, and instead of streets and buildings, there are proteins and strands of RNA and DNA. Then…
STAT
Kindergarten vaccine exemptions are climbing
Doritos as "real" "food," public-sector health care in trouble, and more health news from Morning Rounds
STAT
STAT+: How health care costs are undermining America’s public-sector employers
Politicians are contemplating raising taxes and cutting benefits as the cost of health care for government workers…
STAT
Opinion: 8 steps to making surrogacy more ethical for everyone involved
“Everything about the West case shows how miserably surrogacy has been managed in America,” writes Arthur Caplan.
STAT
Opinion: In parts of the world, antibiotic overuse isn’t the problem — underuse is
“Like climate change, antimicrobial resistance is a global challenge, but its causes and consequences are unevenly…
STAT
STAT+: Doritos as farm-to-table snacks? Big Food, under duress, gets creative
Doritos in the classic nacho cheese flavor have 27 ingredients, including not just familiar ones but also a number of…
STAT
STAT+: Eyepoint study results for vision treatment disappoint, but company still sees promise
Eyepoint said patients given its experimental treatment for wet AMD failed to maintain vision with less frequent…
STAT
STAT+: The IRS is probing UnitedHealth, and a private equity slowdown
UnitedHealth faces an investigation over tax payments, and we examine why PE deals for doctor groups are slowing.
STAT
Everything the Trump administration did on health care last week
17, 2026 Morning Rounds Writer and Reporter Theresa Gaffney[email protected]Theresa is the lead Morning Rounds writer,…
STAT
Opinion: Paid paternity leave is pediatric preventive care
“A growing body of evidence shows that fathers make unique, independent contributions to children's health and…
STAT
Opinion: We proved bipartisan health care reform works in North Carolina. Let’s bring it nationwide
OpinionFirst Opinion We proved bipartisan health care reform works in North Carolina. Let’s bring it nationwide Our…
STAT
STAT+: Epic confronts unprecedented challenges as it prepares to address customers and unveil road map
Mike Reddy for STAT STAT PlusSpecial Report Epic confronts unprecedented challenges as it prepares to address…
STAT
STAT+: UnitedHealth faces IRS probe over potential tax avoidance
The health insurer may face a significant increase in taxes, amid a dispute with federal authorities.
STAT
STAT+: Kennedy’s split-screen week: Talk of vaccines in D.C., fraud and addiction out West
STAT PlusPolitics Kennedy’s split-screen week: Talk of vaccines in D.C., fraud and addiction out West In California,…
STAT
STAT+: State laws may be curbing private equity takeovers of physician group
Private equity deals for practice management firms are declining sharply.
STAT
STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class
The FDA approved a treatment for advanced multiple myeloma made by Bristol Myers Squibb, marking the debut of a new…
STAT
STAT+: An investigation into Commure, and Medicare’s new-tech incentives for AI devices
In this edition of STAT Health Tech: a deep dive into General Catalyst-backed Commure, and Medicare's tech incentives…
STAT
Opinion: How should states reach out to Medicaid enrollees affected by changes? Our research gives a hint
Experts ask: How can we better reach out to people facing Medicaid renewal deadlines and support them through the…
STAT
STAT+: The promise of radiopharmaceuticals smacks into safety concerns
Despite excitement over the potential of radiopharmaceuticals as cancer treatments, drug developers are hitting new…
STAT
Opinion: We prepared for Ebola — but not this Ebola
“Preparedness cannot mean optimizing every investment for yesterday's epidemic,” write Krutika Kuppalli and Placide…
STAT
STAT+: China tightens the reins on clinical trials, even as the U.S. looks for ways to replicate its rival’s speed
China has tightened regulations on investigator-initiated trials, with consequences not just for Chinese researchers…
STAT
STAT+: A shortage of two Sanofi medicines for Pompe disease rattles patients
Sanofi is experiencing shortages of two medicines for Pompe disease, alarming patient groups.
STAT
STAT+: NIH plans to block international researchers on visas from accessing key funding avenue
The NIH plans to close the door on one of the few pathways available to international students on visas to forge a…
STAT
Opinion: One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he was
“The United States invented this platform and is the only country walking away from it,” Jeff Coller writes of mRNA…
STAT
STAT+: Why Schrödinger CEO Ramy Farid changed how he’s thinking about AI
In this edition of STAT's AI Prognosis: Why Schrödinger CEO Ramy Farid is rethinking AI, Recursion's neuron map, and…
STAT
STAT+: Moderna launches early trial of Ebola mRNA vaccine
Novo and Lilly earnings are out, Aurora Therapeutics slashing staff, and more biotech news from The Readout
STAT
Opinion: Something is missing from movies about medical aid in dying
Films and documentaries about assisted dying can narrow the frame of debate, write Anna Magdalena Elsner and Vanessa…
STAT
Opinion: Tear down the wall between M.D. and D.O. education
Having separate systems for M.D.s and D.O.s “is historical inertia dressed as educational diversity,” write physicians…
STAT
MRI is standard for diagnosing prostate cancer in most western countries. But most U.S. men don’t get them
Pre-biopsy MRI is standard outside the U.S., but the latest data show such scans were done in only about a third of…
STAT
STAT+: Senate inquiry suggests Trump administration softened kratom and tobacco policies in quid pro quo
The Senate investigation includes RFK Jr. as well as the heads of Reynolds American and kratom company Botanic Tonics,…
STAT
STAT+: Exemption of rare disease therapies in drug-pricing pilots would wipe out huge savings, analysis finds
Excluding rare disease therapies from a Medicare pilot program to lower drug prices would wipe out much of the savings…
STAT
Ebola kills 1,700 in eastern Congo as the fastest-growing outbreak surges
Ebola has killed more than 1,700 people in eastern Congo in what has become the fastest-growing outbreak of the disease.
STAT
STAT+: California Supreme Court sides with Gilead in ‘duty’ to innovate case
The California Supreme Court sided with Gilead Sciences in a closely watched case over whether the company had a…
STAT
STAT+: Pharmalittle: We’re reading about AstraZeneca-Bristol merger talks, a revised 340B plan, and more
AstraZeneca stock fell as investors balked at reports of merger talks with Bristol Myers Squibb about forming one of…
STAT
New York’s assisted-dying law moves forward
Medicaid work requirements in effect in Nebraska, AI scribes in med school, and more health news from Morning Rounds
STAT
STAT+: BioNTech names Guido Oelkers its new CEO
Guido Oelkers will take over as the new CEO of BioNTech, replacing company cofounder Ugur Sahin.
How WeSearch handles this source
WeSearch's declared handling of STAT News's content. Indexing, snippets, summaries, retrieval and training are separate questions — see the rights registry or read this source's machine-readable record.
Indexing: Allowed
Snippet: Allowed
AI summary: Limited
Retrieval / RAG: Not asserted
Model training: Not asserted
Commercial reuse: Not permitted